These results confirm that that SC66 acts to block AKT, mTORC1 (indicated by p-S6K130,31) and mTORC2 (indicated by p-AKT at Ser 47330,31) in RCC cells (Fig. 3a). Here, AKT1 is linked to renal cell carcinoma.